Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight
Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years.
DelveInsight’s ‘‘Aortic
Stenosis Market Insights, Epidemiology and Market Forecast-2030’' report
delivers an in-depth understanding of the Aortic Stenosis, historical and
forecasted epidemiology as well as the Aortic Stenosis market trends in the
United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
View Report: https://www.delveinsight.com/report-store/aortic-stenosis-market
Request for Sample Page:
https://www.delveinsight.com/sample-request/aortic-stenosis-market
Some key facts of Aortic
Stenosis Market:
·
As per a study by Pujari et al. (2021), the
prevalence of calcific aortic stenosis is about 1% to 2% in patients aged 65 or
more, 12% in patients aged 65 or more, and about 3.4% of patients aged greater
than 75 have severe aortic stenosis.
·
The prevalence of aortic sclerosis ranges from 9-45%
in patients with a mean age of 54 to 81 and increases with age.
·
According to a journal, the prevalence in Japan
of any valve disease is 2.5%. Of those with valve disease, about 0.4% have
aortic stenosis.
·
According to Grave et al. (2020), in 2017, the
guidelines of the European Society of Cardiology and the European Association
for Cardio‐Thoracic Surgery recommended SAVR or TAVI, depending on symptoms, AS
severity, comorbidities, and the
clinical evaluation of the heart team.
Scope of the Aortic
Stenosis Market Report:
- The
report covers the descriptive overview of Aortic Stenosis, explaining its
causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Aortic Stenosis epidemiology and
treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Aortic Stenosis are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Aortic Stenosis market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Aortic Stenosis market
View Report: https://www.delveinsight.com/report-store/aortic-stenosis-market
Request for Sample Page:
https://www.delveinsight.com/sample-request/aortic-stenosis-market
Some of Aortic
Stenosis Companies are:
·
MyoKardia
·
And Many Others
Aortic
Stenosis therapies are:
·
Mavacamten
·
And Many Others
View Report: https://www.delveinsight.com/report-store/aortic-stenosis-market
Request for Sample Page:
https://www.delveinsight.com/sample-request/aortic-stenosis-market
Table of contents:
1. Key Insights
2. Executive Summary
of Aortic Stenosis
3. Competitive
Intelligence Analysis for Aortic Stenosis
4. Aortic Stenosis: Market
Overview at a Glance
4.1. Aortic Stenosis
Total Market Share (%) Distribution in 2018
4.2. Aortic Stenosis
Total Market Share (%) Distribution in 2030
5. Aortic Stenosis:
Disease Background and Overview
5.1. Introduction
5.2. Sign and
Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Aortic Stenosis
Epidemiology and Patient Population
7.1. Epidemiology
Key Findings
7.2. Assumptions and
Rationale: 7MM
7.3. Epidemiology
Scenario: 7MM
7.3.1. Aortic
Stenosis Epidemiology Scenario in the 7MM (2018-2030)
7.4. United States
Epidemiology
7.4.1. Aortic
Stenosis Epidemiology Scenario in the United States (2018-2030)
7.5. EU-5
Country-wise Epidemiology
7.5.1. Germany
Epidemiology
7.5.1.1. Aortic
Stenosis Epidemiology Scenario in Germany (2018-2030)
7.5.2. France
Epidemiology
7.5.2.1. Aortic
Stenosis Epidemiology Scenario in France (2018-2030)
7.5.3. Italy
Epidemiology
7.5.3.1. Aortic
Stenosis Epidemiology Scenario in Italy (2018-2030)
7.5.4. Spain
Epidemiology
7.5.4.1. Aortic
Stenosis Epidemiology Scenario in Spain (2018-2030)
7.5.5. United
Kingdom Epidemiology
7.5.5.1. Aortic
Stenosis Epidemiology Scenario in the United Kingdom (2018-2030)
7.5.6. Japan
Epidemiology
7.5.6.1. Aortic Stenosis
Epidemiology Scenario in Japan (2018-2030)
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Aortic Stenosis
Treatment and Management
8.2. Aortic Stenosis
Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Aortic Stenosis Treatment
11. Marketed
Products
11.1. List of
Marketed Products in the 7MM
11.2. Drug Name:
Company Name
11.2.1. Product
Description
11.2.2. Regulatory
Milestones
11.2.3. Other
Developmental Activities
11.2.4. Pivotal
Clinical Trials
11.2.5. Summary of
Pivotal Clinical Trial
List to be continued
in report
12. Emerging
Therapies
12.1. Key Cross
12.2. Drug Name:
Company Name
12.2.1. Product
Description
12.2.2. Other
Developmental Activities
12.2.3. Clinical
Development
12.2.4. Safety and
Efficacy
12.2.5. Product
Profile
List to be continued
in report
13. Aortic Stenosis:
Seven Major Market Analysis
13.1. Key Findings
13.2. Aortic
Stenosis Market Size in 7MM
13.3. Aortic
Stenosis Market Size by Therapies in the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
15.1. United States:
Market Size
15.1.1. Aortic
Stenosis Total Market Size in the United States
15.1.2. Aortic
Stenosis Market Size by Therapies in the United States
15.2. EU-5
countries: Market Size and Outlook
15.3. Germany Market
Size
15.3.1. Aortic
Stenosis Total Market Size in Germany
15.3.2. Aortic
Stenosis Market Size by Therapies in Germany
15.4. France Market
Size
15.4.1. Aortic
Stenosis Total Market Size in France
15.4.2. Aortic
Stenosis Market Size by Therapies in France
15.5. Italy Market
Size
15.5.1. Aortic
Stenosis Total Market Size in Italy
15.5.2. Aortic
Stenosis Market Size by Therapies in Italy
15.6. Spain Market
Size
15.6.1. Aortic
Stenosis Total Market Size in Spain
15.6.2. Aortic
Stenosis Market Size by Therapies in Spain
15.7. United Kingdom
Market Size
15.7.1. Aortic
Stenosis Total Market Size in the United Kingdom
15.7.2. Aortic
Stenosis Market Size by Therapies in the United Kingdom
15.8. Japan Market
Outlook
15.8.1. Japan Market
Size
15.8.2. Aortic
Stenosis Total Market Size in Japan
15.8.3. Aortic
Stenosis Market Size by Therapies in Japan
16. Access and
Reimbursement Overview of Aortic Stenosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report
Methodology
21. DelveInsight
Capabilities
22. Disclaimer
View Report: https://www.delveinsight.com/report-store/aortic-stenosis-market
Request for Detailed
TOC: https://www.delveinsight.com/sample-request/aortic-stenosis-market
Related Reports:
·
Intrahepatic
Cholangiocarcinoma Market
·
Chemotherapy
Induced Diarrhea Market
·
Immunologic
Deficiency Syndrome Market
·
Acquired
Immunodeficiency Syndrome (AIDS) Market
·
Bladder
pain syndrome Market
·
Carpal
Tunnel Syndrome Market
·
Central
Retinal Venous Occulsion Market
·
Foot
and Ankle Devices Market
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment